Picture of Dispensa logo

DISP Dispensa News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapValue Trap

Issue of Equity & Total Voting Rights

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221111:nRSK2133Ga&default-theme=true

RNS Number : 2133G  Zamaz PLC  11 November 2022

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT
TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK
MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS
DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

11 November 2022

Zamaz plc

"Zamaz" or "the Company"

Issue of Equity & Total Voting Rights

 

Zamaz Plc, the London-based international e-commerce and retail technology
business, announces that it has today issued 3,470,820 Ordinary shares with
nominal value £0.000264640675961774 each (the "Shares") at a price of £0.11
per share in payment for the acquisition by the Company's subsidiary, Bella
Dispensa, of 72.61% of the issued capital of Eccellenze S.r.l.

 

Application has been made for the Shares to be admitted to trading on the
London Stock Exchange ("Admission"). The Shares, which are fully paid, will
rank pari passu in all respects with the existing shares. Admission is
expected to occur on or around 16 November 2022.

 

Total Voting Rights

 

Following the issue of the Shares, the total issued share capital of the
Company will consist of 711,530,255 Ordinary Shares with voting rights. The
Company does not hold any Ordinary Shares in treasury, therefore, the total
number of voting rights in the Company is 711,530,255 and this figure may be
used by shareholders in the Company as the denominator for the calculations by
which they will determine whether they are required to notify their interest
in, or a change in their interest in, the share capital of the Company.

 

For the purposes of UK MAR, the person responsible for arranging release of
this announcement on behalf of Zamaz is Martin Groak, Chairman.

 

- Ends -

 

Enquiries:

 Zamaz plc                        www.zamaz.tech


 Chris Hill, CEO                  c/o Walbrook PR Limited
 Walbrook PR Limited

 Paul Vann/Nick Rome/Joe Walker   Tel: 020 7933 8780

                                  or 07768 807631

                                  zamaz@walbrookpr.com

About Zamaz plc

Zamaz plc is a technology driven e-commerce business that originates,
acquires or licenses, operates and scales small and medium-sized brands with
category-winning products on global marketplaces. With ever prolific customer
data sources, the advent of turnkey e-commerce website platforms, such as
Shopify, and a thriving ecosystem of third-party software integrators, the
options available to launch and build brands that can be marketed, sold, and
shipped online quickly and globally with limited risk have never been more
compelling. Such marketplaces, led by Amazon and eBay, also provide connection
to millions of consumers, and have become a first-choice route-to-market for a
generation of micro and small and medium-sized enterprise businesses.

 

Zamaz mines and analyses data from such online retail technology platforms
which provide significant insights into consumer shopping behaviour and trends
and enable the business to deploy, market and sell an optimised portfolio of
brands, products, packs and prices aligned with active, real-time consumer
needs and demands principally on UK and EU Amazon marketplaces.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBRBDBDUBDGDB

Recent news on Dispensa

See all news